Search research articles
Contact Us
Filters
Showing results (61-70 of 69) with videos related to
Page
of 7
Sort By:
You have reached the last page of results.
This site can display upto 69 results.
Nature Communications
|
March 16, 2023
Clinical outcome and biomarker assessments of a multi-centre phase II trial assessing niraparib with or without dostarlimab in recurrent endometrial carcinoma
Ainhoa Madariaga, Swati Garg, Nairi Tchrakian, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 16, 2018
A Clinical and Molecular Phase II Trial of Oral ENMD-2076 in Ovarian Clear Cell Carcinoma (OCCC): A Study of the Princess Margaret Phase II Consortium
Stephanie Lheureux, Anna Tinker, Blaise Clarke, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
October 21, 2020
Tumor site discordance in mismatch repair deficiency in synchronous endometrial and ovarian cancers
Soyoun Rachel Kim, Alicia Tone, Raymond Kim, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists
|
March 10, 2018
International Society of Gynecological Pathologists (ISGyP) Endometrial Cancer Project: Guidelines From the Special Techniques and Ancillary Studies Group
Kathleen R Cho, Kumarasen Cooper, Sabrina Croce, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
January 11, 2022
Brief family history questionnaire to screen for Lynch syndrome in women with newly diagnosed non-serous, non-mucinous ovarian cancers
Soyoun Rachel Kim, Alicia Tone, Raymond Kim, et al.
Cancer Research
|
March 19, 2011
Targeting tumor hypoxia: suppression of breast tumor growth and metastasis by novel carbonic anhydrase IX inhibitors
Yuanmei Lou, Paul C McDonald, Arusha Oloumi, et al.
The Journal of Pathology
|
August 18, 2012
Molecular characterization of mucinous ovarian tumours supports a stratified treatment approach with HER2 targeting in 19% of carcinomas
Michael S Anglesio, Stefan Kommoss, Mary C Tolcher, et al.
JAMA Oncology
|
November 18, 2017
Association of Ipilimumab With Safety and Antitumor Activity in Women With Metastatic or Recurrent Human Papillomavirus-Related Cervical Carcinoma
Stephanie Lheureux, Marcus O Butler, Blaise Clarke, et al.
Genome Medicine
|
October 27, 2016
Molecular profiling of advanced solid tumors and patient outcomes with genotype-matched clinical trials: the Princess Margaret IMPACT/COMPACT trial
Tracy L Stockley, Amit M Oza, Hal K Berman, et al.
Page
of 7
Search research articles
Search
Showing results (61-70 of 69) with videos related to
Sort By:
Page
of 7
You have reached the last page of results.
This site can display upto 69 results.
Nature Communications
|
March 16, 2023
Clinical outcome and biomarker assessments of a multi-centre phase II trial assessing niraparib with or without dostarlimab in recurrent endometrial carcinoma
Ainhoa Madariaga, Swati Garg, Nairi Tchrakian, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 16, 2018
A Clinical and Molecular Phase II Trial of Oral ENMD-2076 in Ovarian Clear Cell Carcinoma (OCCC): A Study of the Princess Margaret Phase II Consortium
Stephanie Lheureux, Anna Tinker, Blaise Clarke, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
October 21, 2020
Tumor site discordance in mismatch repair deficiency in synchronous endometrial and ovarian cancers
Soyoun Rachel Kim, Alicia Tone, Raymond Kim, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists
|
March 10, 2018
International Society of Gynecological Pathologists (ISGyP) Endometrial Cancer Project: Guidelines From the Special Techniques and Ancillary Studies Group
Kathleen R Cho, Kumarasen Cooper, Sabrina Croce, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
January 11, 2022
Brief family history questionnaire to screen for Lynch syndrome in women with newly diagnosed non-serous, non-mucinous ovarian cancers
Soyoun Rachel Kim, Alicia Tone, Raymond Kim, et al.
Cancer Research
|
March 19, 2011
Targeting tumor hypoxia: suppression of breast tumor growth and metastasis by novel carbonic anhydrase IX inhibitors
Yuanmei Lou, Paul C McDonald, Arusha Oloumi, et al.
The Journal of Pathology
|
August 18, 2012
Molecular characterization of mucinous ovarian tumours supports a stratified treatment approach with HER2 targeting in 19% of carcinomas
Michael S Anglesio, Stefan Kommoss, Mary C Tolcher, et al.
JAMA Oncology
|
November 18, 2017
Association of Ipilimumab With Safety and Antitumor Activity in Women With Metastatic or Recurrent Human Papillomavirus-Related Cervical Carcinoma
Stephanie Lheureux, Marcus O Butler, Blaise Clarke, et al.
Genome Medicine
|
October 27, 2016
Molecular profiling of advanced solid tumors and patient outcomes with genotype-matched clinical trials: the Princess Margaret IMPACT/COMPACT trial
Tracy L Stockley, Amit M Oza, Hal K Berman, et al.
Page
of 7